Company profilePharmaceutical#215 of 1,318 in Pakistan4 DRAP alerts

JAWA PHARMACEUTICALS(PVT) LTD.

Pharmaceutical company · 84 brands · 101 molecules

Ranked #86 of 311 companies in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)

84 registered products 24 pharmaceutical brands 101 distinct molecules 4 DRAP alerts

Company overview

84
registered products
24
pharmaceutical brands
101
distinct molecules
12
therapeutic classes
4
DRAP alerts

JAWA PHARMACEUTICALS(PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 84 product registrations across 101 distinct molecules. Its portfolio is concentrated in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) and Antianemic, Iron Preparations. DRAP has issued 4 alerts involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Therapeutic classes

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 4Antianemic, Iron Preparations · 2Antihistamines For Systemic Use · 2Vitamin B Complex Plain & With Vitamin C · 1Lipid Modifying Agents · 1Antidiarrheals, Intestinal Antiinflammatory/Antiinfective · 1Blood Glucose Lowering Drugs, Excluding Insulin · 1Beta Blocking Agent · 1Drugs For Obstructive Airway Diseases, Systemic · 1Calcium Channel Blockers · 1Ace Inhibitor · 1Other Analgesics And Antipyretics · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official20 products · Rs 3.53 – Rs 2,676.59
Median across source: Rs 630.57

Regulatory record

4 alerts in the DRAP feed we track.

Recall Alert: Drug Product; Pedolil 250mg/5mL Suspension (Batch # 167) by M/S. JASM Pharma
2023-09-22
Recall Alert: Drug Product; Paracet 1g/100mL Infusion by M/s Standpharm Pakistan Pvt Ltd,
2023-01-09
Recall Alert: Drug Product; Kempol 120ml/5mL Pediatric Syrup by M/s Alkemy Pharmaceutical
2022-12-01
Press Release(Availability of Paracetamol )
2022-02-03

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for JAWA

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.